| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | not specified +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (splice donor variant) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +5 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Fanconi anemia +7 more | |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Breast and/or ovarian cancer +5 more | |
| | | Single nucleotide variant (missense variant) | Hereditary breast ovarian cancer syndrome +5 more | |
| | | Single nucleotide variant (missense variant) | Fanconi anemia complementation group O +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | Fanconi anemia complementation group O +1 more | |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O +5 more | |
| | LOC129390903, RAD51C (R212C) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +3 more | |
| | LOC129390903, RAD51C (R214H) | Single nucleotide variant (missense variant +1 more) | not provided +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O +5 more | |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary breast ovarian cancer syndrome +5 more | |
| | | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +5 more | GConflicting classifications of pathogenicity |